Search research articles
Contact Us
Filters
Showing results (51-60 of 114) with videos related to
Page
of 12
Sort By:
Antimicrobial Agents and Chemotherapy
|
February 1, 2012
Extending the definition of the GyrB quinolone resistance-determining region in Mycobacterium tuberculosis DNA gyrase for assessing fluoroquinolone resistance in M. tuberculosis
Alix Pantel, Stéphanie Petrella, Nicolas Veziris, et al.
The Lancet. Infectious Diseases
|
March 15, 2016
Bedaquiline plus delamanid for XDR tuberculosis
Marie Lachâtre, Christophe Rioux, Damien Le Dû, et al.
Frontiers in Microbiology
|
March 7, 2020
Rational Choice of Antibiotics and Media for <i>Mycobacterium avium</i> Complex Drug Susceptibility Testing
Jérémy Jaffré, Alexandra Aubry, Thomas Maitre, et al.
The Journal of Antimicrobial Chemotherapy
|
May 6, 2016
Standardized interpretation of antibiotic susceptibility testing and resistance genotyping for Mycobacterium abscessus with regard to subspecies and erm41 sequevar
Faiza Mougari, Rishma Amarsy, Nicolas Veziris, et al.
Antimicrobial Agents and Chemotherapy
|
September 1, 2010
Should moxifloxacin be used for the treatment of extensively drug-resistant tuberculosis? An answer from a murine model
Julien Poissy, Alexandra Aubry, Christine Fernandez, et al.
The Journal of Infectious Diseases
|
November 21, 2013
In vivo evaluation of antibiotic activity against Mycobacterium abscessus
Isabelle Lerat, Emmanuelle Cambau, Romain Roth Dit Bettoni, et al.
The Journal of Antimicrobial Chemotherapy
|
May 29, 2016
Description of compensatory gyrA mutations restoring fluoroquinolone susceptibility in Mycobacterium tuberculosis
Alix Pantel, Stéphanie Petrella, Nicolas Veziris, et al.
International Journal of Mycobacteriology
|
March 9, 2018
Estimation of pyrazinamidase activity using a cell-free <i>In vitro</i> synthesis of pnca and its association with pyrazinamide susceptibility in <i>Mycobacterium tuberculosis</i>
Daniel Rueda, Christine Bernard, Lucas Gandy, et al.
Emerging Infectious Diseases
|
April 21, 2022
atpE Mutation in Mycobacterium tuberculosis Not Always Predictive of Bedaquiline Treatment Failure
Laure Fournier Le Ray, Alexandra Aubry, Wladimir Sougakoff, et al.
The Journal of Antimicrobial Chemotherapy
|
March 24, 2017
Evaluation of the new GenoType NTM-DR kit for the molecular detection of antimicrobial resistance in non-tuberculous mycobacteria
Faiza Mougari, Jade Loiseau, Nicolas Veziris, et al.
Page
of 12
Search research articles
Search
Showing results (51-60 of 114) with videos related to
Sort By:
Page
of 12
Antimicrobial Agents and Chemotherapy
|
February 1, 2012
Extending the definition of the GyrB quinolone resistance-determining region in Mycobacterium tuberculosis DNA gyrase for assessing fluoroquinolone resistance in M. tuberculosis
Alix Pantel, Stéphanie Petrella, Nicolas Veziris, et al.
The Lancet. Infectious Diseases
|
March 15, 2016
Bedaquiline plus delamanid for XDR tuberculosis
Marie Lachâtre, Christophe Rioux, Damien Le Dû, et al.
Frontiers in Microbiology
|
March 7, 2020
Rational Choice of Antibiotics and Media for <i>Mycobacterium avium</i> Complex Drug Susceptibility Testing
Jérémy Jaffré, Alexandra Aubry, Thomas Maitre, et al.
The Journal of Antimicrobial Chemotherapy
|
May 6, 2016
Standardized interpretation of antibiotic susceptibility testing and resistance genotyping for Mycobacterium abscessus with regard to subspecies and erm41 sequevar
Faiza Mougari, Rishma Amarsy, Nicolas Veziris, et al.
Antimicrobial Agents and Chemotherapy
|
September 1, 2010
Should moxifloxacin be used for the treatment of extensively drug-resistant tuberculosis? An answer from a murine model
Julien Poissy, Alexandra Aubry, Christine Fernandez, et al.
The Journal of Infectious Diseases
|
November 21, 2013
In vivo evaluation of antibiotic activity against Mycobacterium abscessus
Isabelle Lerat, Emmanuelle Cambau, Romain Roth Dit Bettoni, et al.
The Journal of Antimicrobial Chemotherapy
|
May 29, 2016
Description of compensatory gyrA mutations restoring fluoroquinolone susceptibility in Mycobacterium tuberculosis
Alix Pantel, Stéphanie Petrella, Nicolas Veziris, et al.
International Journal of Mycobacteriology
|
March 9, 2018
Estimation of pyrazinamidase activity using a cell-free <i>In vitro</i> synthesis of pnca and its association with pyrazinamide susceptibility in <i>Mycobacterium tuberculosis</i>
Daniel Rueda, Christine Bernard, Lucas Gandy, et al.
Emerging Infectious Diseases
|
April 21, 2022
atpE Mutation in Mycobacterium tuberculosis Not Always Predictive of Bedaquiline Treatment Failure
Laure Fournier Le Ray, Alexandra Aubry, Wladimir Sougakoff, et al.
The Journal of Antimicrobial Chemotherapy
|
March 24, 2017
Evaluation of the new GenoType NTM-DR kit for the molecular detection of antimicrobial resistance in non-tuberculous mycobacteria
Faiza Mougari, Jade Loiseau, Nicolas Veziris, et al.
Page
of 12